X-120530206-ACTGT-A
Position:
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PVS1_ModeratePM2PP5_Moderate
The NM_001079872.2(CUL4B):c.2484_2487delACAG(p.Arg828fs) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Genomes: not found (cov: 22)
Consequence
CUL4B
NM_001079872.2 frameshift
NM_001079872.2 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 9.60
Genes affected
CUL4B (HGNC:2555): (cullin 4B) This gene is a member of the cullin family. The encoded protein forms a complex that functions as an E3 ubiquitin ligase and catalyzes the polyubiquitination of specific protein substrates in the cell. The protein interacts with a ring finger protein, and is required for the proteolysis of several regulators of DNA replication including chromatin licensing and DNA replication factor 1 and cyclin E. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most 50 bp of the penultimate exon, not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.0759 CDS is truncated, and there are 0 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant X-120530206-ACTGT-A is Pathogenic according to our data. Variant chrX-120530206-ACTGT-A is described in ClinVar as [Pathogenic]. Clinvar id is 3364508.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chrX-120530206-ACTGT-A is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CUL4B | NM_001079872.2 | c.2484_2487delACAG | p.Arg828fs | frameshift_variant | 19/20 | ENST00000371322.11 | NP_001073341.1 | |
CUL4B | NM_003588.4 | c.2538_2541delACAG | p.Arg846fs | frameshift_variant | 21/22 | NP_003579.3 | ||
CUL4B | NM_001330624.2 | c.2499_2502delACAG | p.Arg833fs | frameshift_variant | 20/21 | NP_001317553.1 | ||
CUL4B | NM_001369145.1 | c.1950_1953delACAG | p.Arg650fs | frameshift_variant | 19/20 | NP_001356074.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CUL4B | ENST00000371322.11 | c.2484_2487delACAG | p.Arg828fs | frameshift_variant | 19/20 | 1 | NM_001079872.2 | ENSP00000360373.5 | ||
CUL4B | ENST00000681206.1 | c.2598_2601delACAG | p.Arg866fs | frameshift_variant | 22/23 | ENSP00000505480.1 | ||||
CUL4B | ENST00000680673.1 | c.2538_2541delACAG | p.Arg846fs | frameshift_variant | 21/22 | ENSP00000505084.1 | ||||
CUL4B | ENST00000681253.1 | c.2538_2541delACAG | p.Arg846fs | frameshift_variant | 22/23 | ENSP00000506259.1 | ||||
CUL4B | ENST00000681652.1 | c.2538_2541delACAG | p.Arg846fs | frameshift_variant | 24/25 | ENSP00000505176.1 | ||||
CUL4B | ENST00000336592.11 | c.2499_2502delACAG | p.Arg833fs | frameshift_variant | 20/21 | 5 | ENSP00000338919.6 | |||
CUL4B | ENST00000674137.11 | c.2490_2493delACAG | p.Arg830fs | frameshift_variant | 19/20 | ENSP00000501019.6 | ||||
CUL4B | ENST00000681090.1 | c.2391_2394delACAG | p.Arg797fs | frameshift_variant | 19/20 | ENSP00000506288.1 | ||||
CUL4B | ENST00000679927.1 | c.2139_2142delACAG | p.Arg713fs | frameshift_variant | 20/21 | ENSP00000505603.1 | ||||
CUL4B | ENST00000371323.3 | c.1950_1953delACAG | p.Arg650fs | frameshift_variant | 19/20 | 5 | ENSP00000360374.3 | |||
CUL4B | ENST00000680474.1 | c.1926_1929delACAG | p.Arg642fs | frameshift_variant | 18/20 | ENSP00000505562.1 | ||||
CUL4B | ENST00000679844.1 | c.1821_1824delACAG | p.Arg607fs | frameshift_variant | 17/18 | ENSP00000505239.1 | ||||
CUL4B | ENST00000404115.8 | c.2439+2212_2439+2215delACAG | intron_variant | 1 | ENSP00000384109.4 | |||||
CUL4B | ENST00000673919.1 | n.*1931_*1934delACAG | non_coding_transcript_exon_variant | 20/21 | ENSP00000500994.1 | |||||
CUL4B | ENST00000674073.2 | n.*40_*43delACAG | non_coding_transcript_exon_variant | 17/18 | ENSP00000501262.2 | |||||
CUL4B | ENST00000679405.1 | n.*1693_*1696delACAG | non_coding_transcript_exon_variant | 21/22 | ENSP00000504985.1 | |||||
CUL4B | ENST00000679432.1 | n.*1693_*1696delACAG | non_coding_transcript_exon_variant | 21/22 | ENSP00000505343.1 | |||||
CUL4B | ENST00000680918.1 | n.*1400_*1403delACAG | non_coding_transcript_exon_variant | 17/18 | ENSP00000505955.1 | |||||
CUL4B | ENST00000681080.1 | n.*1693_*1696delACAG | non_coding_transcript_exon_variant | 19/20 | ENSP00000505898.1 | |||||
CUL4B | ENST00000681189.1 | n.*650_*653delACAG | non_coding_transcript_exon_variant | 19/20 | ENSP00000505973.1 | |||||
CUL4B | ENST00000681333.1 | n.*3377_*3380delACAG | non_coding_transcript_exon_variant | 16/17 | ENSP00000505739.1 | |||||
CUL4B | ENST00000681908.1 | n.*656_*659delACAG | non_coding_transcript_exon_variant | 19/20 | ENSP00000505777.1 | |||||
CUL4B | ENST00000673919.1 | n.*1931_*1934delACAG | 3_prime_UTR_variant | 20/21 | ENSP00000500994.1 | |||||
CUL4B | ENST00000674073.2 | n.*40_*43delACAG | 3_prime_UTR_variant | 17/18 | ENSP00000501262.2 | |||||
CUL4B | ENST00000679405.1 | n.*1693_*1696delACAG | 3_prime_UTR_variant | 21/22 | ENSP00000504985.1 | |||||
CUL4B | ENST00000679432.1 | n.*1693_*1696delACAG | 3_prime_UTR_variant | 21/22 | ENSP00000505343.1 | |||||
CUL4B | ENST00000680918.1 | n.*1400_*1403delACAG | 3_prime_UTR_variant | 17/18 | ENSP00000505955.1 | |||||
CUL4B | ENST00000681080.1 | n.*1693_*1696delACAG | 3_prime_UTR_variant | 19/20 | ENSP00000505898.1 | |||||
CUL4B | ENST00000681189.1 | n.*650_*653delACAG | 3_prime_UTR_variant | 19/20 | ENSP00000505973.1 | |||||
CUL4B | ENST00000681333.1 | n.*3377_*3380delACAG | 3_prime_UTR_variant | 16/17 | ENSP00000505739.1 | |||||
CUL4B | ENST00000681908.1 | n.*656_*659delACAG | 3_prime_UTR_variant | 19/20 | ENSP00000505777.1 |
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD3 genomes
Cov.:
22
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome Cov.: 22
GnomAD4 genome
Cov.:
22
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Apr 15, 2024 | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 29302074) - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.